Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps.

Taylor KA, Forlenza GP.

Diabetes Technol Ther. 2020 Feb 14. doi: 10.1089/dia.2020.0026. [Epub ahead of print]

PMID:
32058821
2.

Randomized Controlled Trial of Mobile Closed-Loop Control.

Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ 3rd, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW; iDCL Study Group.

Diabetes Care. 2020 Mar;43(3):607-615. doi: 10.2337/dc19-1310. Epub 2020 Jan 14.

PMID:
31937608
3.

Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months.

Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP.

Pediatr Diabetes. 2020 Mar;21(2):319-327. doi: 10.1111/pedi.12971. Epub 2020 Jan 3.

PMID:
31885123
4.

Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.

Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP.

Pediatr Diabetes. 2020 Mar;21(2):310-318. doi: 10.1111/pedi.12962. Epub 2020 Jan 7.

PMID:
31837064
5.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW; iDCL Trial Research Group.

N Engl J Med. 2019 Oct 31;381(18):1707-1717. doi: 10.1056/NEJMoa1907863. Epub 2019 Oct 16.

PMID:
31618560
6.

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.

Sherr JL, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu L, Berget C, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2020 Mar;22(3):174-184. doi: 10.1089/dia.2019.0286. Epub 2019 Oct 29.

PMID:
31596130
7.

MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.

Saunders A, Messer LH, Forlenza GP.

Expert Rev Med Devices. 2019 Oct;16(10):845-853. doi: 10.1080/17434440.2019.1670639. Epub 2019 Sep 30. Review.

PMID:
31540557
8.

A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.

Berget C, Messer LH, Forlenza GP.

Diabetes Spectr. 2019 Aug;32(3):194-204. doi: 10.2337/ds18-0091.

PMID:
31462873
9.

Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy.

Forlenza GP.

Diabetes Technol Ther. 2019 Jun;21(S2):S24-S28. doi: 10.1089/dia.2019.0077. No abstract available.

PMID:
31169433
10.

A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.

Messer LH, Berget C, Forlenza GP.

Diabetes Technol Ther. 2019 Aug;21(8):462-469. doi: 10.1089/dia.2019.0105. Epub 2019 May 29. No abstract available.

PMID:
31140878
11.

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.

Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD.

Pediatr Diabetes. 2019 Sep;20(6):759-768. doi: 10.1111/pedi.12867. Epub 2019 May 23.

12.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.

Forlenza GP, Buckingham BA, Christiansen MP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2019 May;21(5):265-272. doi: 10.1089/dia.2019.0017. Epub 2019 Mar 29.

13.

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.

Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D.

Diabetes Technol Ther. 2019 Apr;21(4):159-169. doi: 10.1089/dia.2019.0011. Epub 2019 Mar 19.

PMID:
30888835
14.

Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear.

Forlenza GP, Kushner T, Messer LH, Wadwa RP, Sankaranarayanan S.

Diabetes Technol Ther. 2019 Apr;21(4):222-229. doi: 10.1089/dia.2018.0401. Epub 2019 Feb 28.

PMID:
30817171
15.

Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.

Sopfe J, Pyle L, Keating AK, Campbell K, Liu AK, Wadwa RP, Verneris MR, Giller RH, Forlenza GP.

Blood Adv. 2019 Feb 12;3(3):350-359. doi: 10.1182/bloodadvances.2018021014.

16.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

17.

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.

Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, Shulman DI, Bailey TS, Bode BW, Wood MA, Buckingham BA, Kaiserman KB, Shin J, Huang S, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2019 Jan;21(1):11-19. doi: 10.1089/dia.2018.0264. Epub 2018 Dec 26.

18.

In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.

Wood MA, Shulman DI, Forlenza GP, Bode BW, Pinhas-Hamiel O, Buckingham BA, Kaiserman KB, Liljenquist DR, Bailey TS, Shin J, Huang S, Chen X, Cordero TL, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2018 Nov;20(11):731-737. doi: 10.1089/dia.2018.0209. Epub 2018 Oct 6.

PMID:
30299976
19.

Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA.

Curr Diab Rep. 2018 Sep 26;18(11):114. doi: 10.1007/s11892-018-1078-1. Review.

20.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.

Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, Wadwa RP, Ekhlaspour L, Church MM, Weinzimer SA, Jost E, Marcal T, Andre C, Carria L, Swanson V, Lum JW, Kollman C, Woodall W, Beck RW.

Diabetes Care. 2018 Oct;41(10):2155-2161. doi: 10.2337/dc18-0771. Epub 2018 Aug 8.

PMID:
30089663
21.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Buckingham BA, Christiansen MP, Forlenza GP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

22.

Preserving Skin Integrity with Chronic Device Use in Diabetes.

Messer LH, Berget C, Beatson C, Polsky S, Forlenza GP.

Diabetes Technol Ther. 2018 Jun;20(S2):S254-S264. doi: 10.1089/dia.2018.0080.

23.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Forlenza GP, Cameron FM, Ly TT, Lam D, Howsmon DP, Baysal N, Kulina G, Messer L, Clinton P, Levister C, Patek SD, Levy CJ, Wadwa RP, Maahs DM, Bequette BW, Buckingham BA.

Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.

24.

Ongoing Debate About Models for Artificial Pancreas Systems and In Silico Studies.

Forlenza GP.

Diabetes Technol Ther. 2018 Mar;20(3):174-176. doi: 10.1089/dia.2018.0038. No abstract available.

25.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH.

Diabetes Care. 2018 Apr;41(4):789-796. doi: 10.2337/dc17-1682. Epub 2018 Feb 14.

26.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.

27.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.

Howsmon DP, Baysal N, Buckingham BA, Forlenza GP, Ly TT, Maahs DM, Marcal T, Towers L, Mauritzen E, Deshpande S, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Dassau E, Hahn J, Bequette BW.

J Diabetes Sci Technol. 2018 May;12(3):599-607. doi: 10.1177/1932296818755173. Epub 2018 Feb 1.

28.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.

J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 1.

29.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.

Forlenza GP, Raghinaru D, Cameron F, Wayne Bequette B, Peter Chase H, Paul Wadwa R, Maahs DM, Jost E, Ly TT, Wilson DM, Norlander L, Ekhlaspour L, Min H, Clinton P, Njeru N, Lum JW, Kollman C, Beck RW, Buckingham BA; In-Home Closed-Loop (IHCL) Study Group.

Pediatr Diabetes. 2018 May;19(3):420-428. doi: 10.1111/pedi.12603. Epub 2017 Nov 20.

30.

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 8. No abstract available.

31.

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.

Breton MD, Cherñavvsky DR, Forlenza GP, DeBoer MD, Robic J, Wadwa RP, Messer LH, Kovatchev BP, Maahs DM.

Diabetes Care. 2017 Dec;40(12):1644-1650. doi: 10.2337/dc17-0883. Epub 2017 Aug 30.

32.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW.

Diabetes Technol Ther. 2017 Sep;19(9):527-532. doi: 10.1089/dia.2017.0078. Epub 2017 Aug 2.

33.

Relevance of Bolus Calculators in Current Hybrid Closed Loop Systems.

Forlenza GP.

Diabetes Technol Ther. 2017 Jul;19(7):400-401. doi: 10.1089/dia.2017.0216. Epub 2017 Jul 7. No abstract available.

34.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM.

Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27. No abstract available.

PMID:
28656656
35.

Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use.

Forlenza GP, Argento NB, Laffel LM.

Diabetes Technol Ther. 2017 Jun;19(S3):S13-S20. doi: 10.1089/dia.2017.0034. Review.

36.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Aug;40(8):1096-1102. doi: 10.2337/dc17-0500. Epub 2017 Jun 5. Erratum in: Diabetes Care. 2017 Sep 8;:.

37.

Sporadic Insulinoma Presenting as Early Morning Night Terrors.

Beisang D, Forlenza GP, Luquette M, Sarafoglou K.

Pediatrics. 2017 Jun;139(6). pii: e20162007. doi: 10.1542/peds.2016-2007.

38.

Artificial Pancreas in Young Children.

Ohman-Hanson RA, Forlenza GP.

Diabetes Technol Ther. 2017 May;19(5):277-279. doi: 10.1089/dia.2017.0126. No abstract available.

39.

Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes.

Zhong VW, Crandell JL, Shay CM, Gordon-Larsen P, Cole SR, Juhaeri J, Kahkoska AR, Maahs DM, Seid M, Forlenza GP, Mayer-Davis EJ.

J Diabetes Complications. 2017 Aug;31(8):1340-1347. doi: 10.1016/j.jdiacomp.2017.04.017. Epub 2017 Apr 20.

40.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ 3rd, Pinsker JE, Maahs DM, Buckingham BA, Dassau E.

Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1.

41.

Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.

Forlenza GP.

Diabetes Technol Ther. 2017 Apr;19(4):206-208. doi: 10.1089/dia.2017.0048. No abstract available.

42.

Total Pancreatectomy With Islet Autotransplantation Resolves Pain in Young Children With Severe Chronic Pancreatitis.

Bellin MD, Forlenza GP, Majumder K, Berger M, Freeman ML, Beilman GJ, Dunn TB, Pruett TL, Murati M, Wilhelm JJ, Cook M, Sutherland DE, Schwarzenberg SJ, Chinnakotla S.

J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):440-445. doi: 10.1097/MPG.0000000000001314.

43.

Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.

Sarafoglou K, Forlenza GP, Yaw Addo O, Kyllo J, Lteif A, Hindmarsh PC, Petryk A, Gonzalez-Bolanos MT, Miller BS, Thomas W.

Clin Endocrinol (Oxf). 2017 May;86(5):708-716. doi: 10.1111/cen.13313. Epub 2017 Mar 28.

44.

Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.

Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT; In-Home Closed-Loop (IHCL) Study Group.

Diabetes Care. 2017 Mar;40(3):359-366. doi: 10.2337/dc16-1794. Epub 2017 Jan 18.

45.

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs).

Howsmon DP, Cameron F, Baysal N, Ly TT, Forlenza GP, Maahs DM, Buckingham BA, Hahn J, Bequette BW.

Sensors (Basel). 2017 Jan 15;17(1). pii: E161. doi: 10.3390/s17010161.

46.

Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.

Forlenza GP, Pyle LL, Maahs DM, Dunn TC.

Pediatr Diabetes. 2017 Nov;18(7):622-628. doi: 10.1111/pedi.12474. Epub 2016 Nov 23.

PMID:
27878929
47.

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.

Karlin AW, Ly TT, Pyle L, Forlenza GP, Messer L, Wadwa RP, DeSalvo DJ, Payne SL, Hanes S, Clinton P, Maahs DM, Buckingham B.

Diabetes Technol Ther. 2016 Jul;18(7):429-35. doi: 10.1089/dia.2015.0432. Epub 2016 May 26.

48.

Accuracy of Continuous Glucose Monitoring in Patients After Total Pancreatectomy with Islet Autotransplantation.

Forlenza GP, Nathan BM, Moran A, Dunn TB, Beilman GJ, Pruett TL, Kovatchev BP, Bellin MD.

Diabetes Technol Ther. 2016 Aug;18(8):455-63. doi: 10.1089/dia.2015.0405. Epub 2016 Apr 22.

49.

Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation.

Forlenza GP, Nathan BM, Moran AM, Dunn TB, Beilman GJ, Pruett TL, Bellin MD.

Am J Transplant. 2016 Feb;16(2):527-34. doi: 10.1111/ajt.13539. Epub 2015 Nov 20.

50.

Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas.

Forlenza GP, Buckingham B, Maahs DM.

J Pediatr. 2016 Feb;169:13-20. doi: 10.1016/j.jpeds.2015.10.015. Epub 2015 Nov 5. No abstract available.

Supplemental Content

Loading ...
Support Center